IE
MXCT icon

Israel Englander’s MaxCyte MXCT Stock Holding History

Israel Englander’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48M Buy
1,204,921
+1,161,862
+2,698% +$1.16M ﹤0.01% 4056
2026
Q1 		$30.2K Sell
43,059
-1,249,714
-97% -$1.17M ﹤0.01% 5474
2025
Q4 		$2M Buy
1,292,773
+1,183,461
+1,083% +$1.89M ﹤0.01% 3953
2025
Q3 		$173K Sell
109,312
-53,838
-33% -$93.6K ﹤0.01% 5585
2025
Q2 		$356K Sell
163,150
-1,215,179
-88% -$2.94M ﹤0.01% 5105
2025
Q1 		$3.76M Sell
1,378,329
-1,362,542
-50% -$5.37M ﹤0.01% 3143
2024
Q4 		$11.4M Sell
2,740,871
-1,451,994
-35% -$5.49M 0.01% 2061
2024
Q3 		$16.3M Sell
4,192,865
-985,088
-19% -$4.15M 0.01% 1736
2024
Q2 		$20.3M Sell
5,177,953
-993,093
-16% -$4.27M 0.01% 1489
2024
Q1 		$25.9M Buy
6,171,046
+1,158,763
+23% +$5.44M 0.01% 1329
2023
Q4 		$23.6M Buy
5,012,283
+1,165,642
+30% +$4.54M 0.01% 1406
2023
Q3 		$12M Buy
3,846,641
+1,909,649
+99% +$7.68M 0.01% 1881
2023
Q2 		$8.89M Sell
1,936,992
-910,161
-32% -$4.18M ﹤0.01% 2134
2023
Q1 		$14.1M Buy
2,847,153
+948,640
+50% +$4.67M 0.01% 1639
2022
Q4 		$10.4M Buy
1,898,513
+474,178
+33% +$2.91M 0.01% 2086
2022
Q3 		$9.26M Sell
1,424,335
-930,751
-40% -$5.19M 0.01% 2248
2022
Q2 		$11.1M Buy
2,355,086
+947,104
+67% +$4.66M 0.01% 1919
2022
Q1 		$9.84M Buy
+1,407,982
New +$9.61M 0.01% 2189
2021
Q4 		– Sell
-422,442
Closed -$5.16M – 7172
2021
Q3 		$5.16M Buy
+422,442
New +$6.37M ﹤0.01% 2826

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Israel Englander's MXCT Position: Q2 2026 in Review

Israel Englander increased its MaxCyte (MXCT) stake by 2,698% in Q2 2026, buying an estimated $1.16M and bringing the position to 1,204,921 shares worth $1.48M. The position accounts for ﹤0.01% of the portfolio, ranked #4056.

Israel Englander first reported a position in MXCT in Q3 2021 and has held it in 19 quarters since. The position peaked at $25.9M in Q1 2024. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Israel Englander held 1,204,921 shares of MaxCyte worth $1.48M as of Q2 2026.
  • Israel Englander bought 1,161,862 MaxCyte shares in Q2 2026, an estimated $1.16M.
  • MaxCyte made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4056 holding.
  • Israel Englander first reported a position in MaxCyte in Q3 2021 and has held it in 19 quarters since.
  • Israel Englander's MaxCyte position peaked at $25.9M in Q1 2024.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.